Henry Schein, Inc. (HSIC) has seen significant movements recently. As set by analysts, its price target is reported to be at $80.10. The company announced a strategic investment by KKR, including changes to the board and preliminary unaudited financial results. This news came simultaneously with the news that Provident Healthcare Partners has advised Acentus on its acquisition by Henry Schein. HSIC is also expected to publish its Q4 2024 Earnings Release and host a conference call with its CEO. Concerning its valuation, Henry Schein seems potentially undervalued as per recent reports. Big names such as Private Management Group Inc and Robeco Institutional Asset Management B.V. have increased their stakes in HSIC, and KKR has also shown significant interest by making a $250M strategic investment. Meanwhile, Henry Schein Inc's financials are deemed too ambiguous in its correlation with the current share price momentum, raising some concerns. Moreover, HSIC also received an upgraded price target of $90.00 from Barrington Research while there's notable caution as insiders at Henry Schein are reported to have sold US$3.4m in stock.
Henry Schein HSIC News Analytics from Tue, 27 Feb 2024 08:00:00 GMT to Sat, 08 Feb 2025 16:33:49 GMT -
Rating 6
- Innovation 4
- Information 8
- Rumor 2
